Researchmoz added Most up-to-date research on "Global Cancer Immunotherapies Market 2016-2020" to its huge collection of research reports.
Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies have fewer side effects and can treat different types of cancer. Cancer immunotherapies make up nearly 50% of the cancer drugs market.
Technavios analysts forecast the global cancer immunotherapies market to grow at a CAGR of 15.17% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global cancer immunotherapies market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of cancer immunotherapies used to treat cancer.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=715922
Technavio's report, Global Cancer Immunotherapies Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Amgen
Bristol-Myers Squibb
F. Hoffmann-La Roche
GlaxoSmithKline
Merck
Takeda Pharmaceuticals
Other prominent vendors
AbbVie
ADC Therapeutics
Agensys
Astellas
AstraZeneca
Bayer
Biogen
Biotech Pharmaceutical
Boehringer-Ingelheim
Celgene
Celldex Therapeutics
Chugai Pharmaceutical
CTI Biopharma
Daiichi Sankyo
Eli Lilly
Fortress Biotech
Genmab
Immunomedics
Intas Pharmaceuticals
Janssen Biotech
Kyowa Hakko Kirin
MedImmune
Morphotek
Neovii Biotech
Novartis
OncoMed Pharmaceuticals
Pfizer
Sanofi
Seattle Genetics
Spectrum Pharmaceuticals
TG Therapeutics
XBiotech
Market driver
Increase in demand for cancer monoclonal antibodies
For a full, detailed list, view our report
Market challenge
Patent expiry of top-selling drugs
For a full, detailed list, view our report
Market trend
Emergence of targeted and combination therapies
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=715922
Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies have fewer side effects and can treat different types of cancer. Cancer immunotherapies make up nearly 50% of the cancer drugs market.
Technavios analysts forecast the global cancer immunotherapies market to grow at a CAGR of 15.17% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global cancer immunotherapies market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of cancer immunotherapies used to treat cancer.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=715922
Technavio's report, Global Cancer Immunotherapies Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Amgen
Bristol-Myers Squibb
F. Hoffmann-La Roche
GlaxoSmithKline
Merck
Takeda Pharmaceuticals
Other prominent vendors
AbbVie
ADC Therapeutics
Agensys
Astellas
AstraZeneca
Bayer
Biogen
Biotech Pharmaceutical
Boehringer-Ingelheim
Celgene
Celldex Therapeutics
Chugai Pharmaceutical
CTI Biopharma
Daiichi Sankyo
Eli Lilly
Fortress Biotech
Genmab
Immunomedics
Intas Pharmaceuticals
Janssen Biotech
Kyowa Hakko Kirin
MedImmune
Morphotek
Neovii Biotech
Novartis
OncoMed Pharmaceuticals
Pfizer
Sanofi
Seattle Genetics
Spectrum Pharmaceuticals
TG Therapeutics
XBiotech
Market driver
Increase in demand for cancer monoclonal antibodies
For a full, detailed list, view our report
Market challenge
Patent expiry of top-selling drugs
For a full, detailed list, view our report
Market trend
Emergence of targeted and combination therapies
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=715922
No comments:
Post a Comment